Search results
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 5 days agoPeople who depend on daily insulin shots may soon have welcome news: a new experimental drug could...
Morgan Wallen serves up the hits to big MetLife crowd, including Eli Manning: Review
App.com | Asbury Park Press via Yahoo News· 3 days agoWallen, a native of Tennessee, played his hits with his six-member band in a close to two-hour show...
The O List: Summer Fun Edition
The Oprah Magazine via Yahoo News· 21 hours agoThe O List: Summer Fun EditionPhotographer Eli Schmidt. Prop Styling Julie Flynn We’re not going to play favorites, but when it comes to seasons, there’s...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 6 days agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks via Yahoo Finance· 6 days agoEli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...
Playbook: Where the left is on the run
Politico· 7 hours agoWith help from Eli Okun, Garrett Ross and Bethany Irvine WHISKEY TANGO FOXTROT — “Trump’s social media account shares video referencing ‘unified reich,’” by Natalie Allison ...
Connecticut high school baseball top performances, games to watch (May 21)
The News-Times· 45 minutes agoHere are the top performances in baseball from the past week, along with some key games to go check...
Aktis to collaborate with Eli Lilly on cancer therapies
AOL· 7 hours agoThe Boston-based drug developer will use its proprietary technology along with Lilly's expertise in oncology drugs to develop therapies for a range of solid tumors. The company will receive ...
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
The Motley Fool via AOL· 2 days agoEli Lilly (NYSE: LLY) sells a broad portfolio of products, but two in particular have helped revenue...
How Are Eli Lilly’s Profit Margins Trending?
Forbes· 7 days agoEli Lilly (NYSE: LLY) saw its net income decline by $1 billion or 16% y-o-y to $5.2 billion in 2023. This can primarily be attributed to higher acquired...
